Furthermore, RRM1 alteration after gemcitabine exposure was significantly scant in PSN1 cells (S3 Fig), which are gemcitabine-sensitive in pancreatic cancer cells lines. The gene discussed is NT5C3A; the disease is pancreatic neoplasm.